BCRX logo

BioCryst Pharmaceuticals, Inc. (BCRX) Retained Earnings

Annual Retained Earnings:

-$1.77B-$88.88M(-5.29%)
December 31, 2024

Summary

  • As of today, BCRX annual retained earnings is -$1.77 billion, with the most recent change of -$88.88 million (-5.29%) on December 31, 2024.
  • During the last 3 years, BCRX annual retained earnings has fallen by -$562.54 million (-46.59%).
  • BCRX annual retained earnings is now -8132.74% below its all-time high of -$21.50 million, reached on December 31, 1994.

Performance

BCRX Retained Earnings Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherBCRXbalance sheet metrics

Quarterly Retained Earnings:

-$1.76B+$5.08M(+0.29%)
June 30, 2025

Summary

  • As of today, BCRX quarterly retained earnings is -$1.76 billion, with the most recent change of +$5.08 million (+0.29%) on June 30, 2025.
  • Over the past year, BCRX quarterly retained earnings has dropped by -$35.71 million (-2.07%).
  • BCRX quarterly retained earnings is now -10862.25% below its all-time high of -$16.10 million, reached on March 31, 1994.

Performance

BCRX Quarterly Retained Earnings Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherBCRXbalance sheet metrics

Retained Earnings Formula

Retained Earnings = Retained Earnings (start of the period) + Net Income − Dividends Paid

BCRX Retained Earnings Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterly
1Y1 Year-5.3%-2.1%
3Y3 Years-46.6%-31.7%
5Y5 Years-110.6%-92.5%

BCRX Retained Earnings Highs & Lows

PeriodPeriodAnnual vs HighAnnual vs HighAnnual vs LowAnnual vs LowQuarter. vs HighQuarter. vs HighQuarter. vs LowQuarter. vs Low
3Y3-Year-46.6%at low-27.6%+0.3%
5Y5-Year-110.6%at low-83.3%+0.3%
All-TimeAll-Time-8132.7%at low>-9999.0%+0.3%

BCRX Retained Earnings History

DateAnnualQuarterly
Jun 2025
-
-$1.76B(+0.3%)
Mar 2025
-
-$1.77B(+0.0%)
Dec 2024
-$1.77B(-5.3%)
-$1.77B(-1.5%)
Sep 2024
-
-$1.74B(-0.8%)
Jun 2024
-
-$1.73B(-0.7%)
Mar 2024
-
-$1.72B(-2.1%)
Dec 2023
-$1.68B(-15.6%)
-$1.68B(-3.8%)
Sep 2023
-
-$1.62B(-2.3%)
Jun 2023
-
-$1.58B(-5.0%)
Mar 2023
-
-$1.51B(-3.7%)
Dec 2022
-$1.45B(-20.5%)
-$1.45B(-5.2%)
Sep 2022
-
-$1.38B(-3.2%)
Jun 2022
-
-$1.34B(-4.6%)
Mar 2022
-
-$1.28B(-6.1%)
Dec 2021
-$1.21B(-18.0%)
-$1.21B(-1.5%)
Sep 2021
-
-$1.19B(-5.2%)
Jun 2021
-
-$1.13B(-4.0%)
Mar 2021
-
-$1.09B(-6.3%)
Dec 2020
-$1.02B(-21.7%)
-$1.02B(-6.3%)
Sep 2020
-
-$962.95M(-5.0%)
Jun 2020
-
-$916.83M(-4.4%)
Mar 2020
-
-$878.23M(-4.5%)
Dec 2019
-$840.63M(-14.8%)
-$840.63M(-0.3%)
Sep 2019
-
-$838.01M(-4.7%)
Jun 2019
-
-$800.41M(-4.9%)
Mar 2019
-
-$762.78M(-4.2%)
Dec 2018
-$731.97M(-15.8%)
-$731.97M(-3.9%)
Sep 2018
-
-$704.54M(-4.4%)
Jun 2018
-
-$674.94M(-2.8%)
Mar 2018
-
-$656.49M(-3.9%)
Dec 2017
-$631.84M(-11.6%)
-$631.84M(-3.2%)
Sep 2017
-
-$612.30M(-2.5%)
Jun 2017
-
-$597.17M(-2.9%)
Mar 2017
-
-$580.28M(-2.5%)
Dec 2016
-$566.06M(-10.8%)
-$566.06M(-0.8%)
Sep 2016
-
-$561.56M(-2.1%)
Jun 2016
-
-$550.03M(-3.1%)
Mar 2016
-
-$533.75M(-4.5%)
Dec 2015
-$510.92M(-9.2%)
-$510.92M(-3.7%)
Sep 2015
-
-$492.78M(-3.1%)
Jun 2015
-
-$478.16M(+1.0%)
Mar 2015
-
-$483.06M(-3.2%)
Dec 2014
-$467.90M(-10.7%)
-$467.90M(-2.6%)
Sep 2014
-
-$456.23M(-2.0%)
Jun 2014
-
-$447.50M(-3.4%)
Mar 2014
-
-$432.85M(-2.4%)
Dec 2013
-$422.71M(-7.7%)
-$422.71M(-1.3%)
Sep 2013
-
-$417.28M(-2.0%)
Jun 2013
-
-$409.28M(-3.1%)
Mar 2013
-
-$397.11M(-1.1%)
Dec 2012
-$392.60M(-11.1%)
-$392.60M(-2.9%)
Sep 2012
-
-$381.55M(-2.6%)
Jun 2012
-
-$371.85M(-3.4%)
Mar 2012
-
-$359.57M(-1.7%)
Dec 2011
-$353.52M(-19.2%)
-$353.52M(-3.9%)
Sep 2011
-
-$340.33M(-4.4%)
Jun 2011
-
-$325.87M(-5.3%)
Mar 2011
-
-$309.60M(-4.4%)
Dec 2010
-$296.57M(-12.9%)
-$296.57M(-3.6%)
Sep 2010
-
-$286.37M(-3.9%)
Jun 2010
-
-$275.51M(-3.8%)
Mar 2010
-
-$265.31M(-1.0%)
Dec 2009
-$262.72M
-$262.72M(+5.5%)
DateAnnualQuarterly
Sep 2009
-
-$277.87M(-4.0%)
Jun 2009
-
-$267.24M(-3.4%)
Mar 2009
-
-$258.56M(-3.7%)
Dec 2008
-$249.27M(-11.0%)
-$249.27M(+3.9%)
Sep 2008
-
-$259.34M(-3.6%)
Jun 2008
-
-$250.34M(-5.3%)
Mar 2008
-
-$237.63M(-5.8%)
Dec 2007
-$224.54M(-14.9%)
-$224.54M(-1.0%)
Sep 2007
-
-$222.25M(-5.2%)
Jun 2007
-
-$211.27M(-3.4%)
Mar 2007
-
-$204.31M(-4.5%)
Dec 2006
-$195.48M(-28.7%)
-$195.48M(-5.4%)
Sep 2006
-
-$185.43M(-9.2%)
Jun 2006
-
-$169.83M(-6.3%)
Mar 2006
-
-$159.75M(-5.2%)
Dec 2005
-$151.86M(-20.8%)
-$151.86M(-4.9%)
Sep 2005
-
-$144.70M(-5.6%)
Jun 2005
-
-$137.06M(-4.3%)
Mar 2005
-
-$131.41M(-4.5%)
Dec 2004
-$125.76M(-20.2%)
-$125.76M(-4.4%)
Sep 2004
-
-$120.47M(-4.6%)
Jun 2004
-
-$115.18M(-4.6%)
Mar 2004
-
-$110.12M(-5.2%)
Dec 2003
-$104.66M(-13.8%)
-$104.66M(-3.2%)
Sep 2003
-
-$101.41M(-3.5%)
Jun 2003
-
-$98.00M(-3.4%)
Mar 2003
-
-$94.75M(-3.0%)
Dec 2002
-$91.96M(-22.6%)
-$91.96M(-3.1%)
Sep 2002
-
-$89.22M(-4.0%)
Jun 2002
-
-$85.81M(-6.4%)
Mar 2002
-
-$80.65M(-7.5%)
Dec 2001
-$75.03M(-7.1%)
-$75.03M(-7.1%)
Sep 2001
-
-$70.05M(+0.6%)
Jun 2001
-
-$70.47M(+1.3%)
Mar 2001
-
-$71.43M(-2.0%)
Dec 2000
-$70.05M(-19.7%)
-$70.05M(-16.3%)
Sep 2000
-
-$60.25M(-2.8%)
Jun 2000
-
-$58.60M(-3.5%)
Mar 2000
-
-$56.61M(+3.2%)
Dec 1999
-$58.50M(-10.0%)
-$58.50M(-0.9%)
Sep 1999
-
-$58.00M(-3.9%)
Jun 1999
-
-$55.80M(-0.4%)
Mar 1999
-
-$55.60M(-4.5%)
Dec 1998
-$53.20M(-9.9%)
-$53.20M(-2.9%)
Sep 1998
-
-$51.70M(+5.0%)
Jun 1998
-
-$54.40M(-5.8%)
Mar 1998
-
-$51.40M(-6.2%)
Dec 1997
-$48.40M(-28.0%)
-$48.40M(-6.4%)
Sep 1997
-
-$45.50M(-5.8%)
Jun 1997
-
-$43.00M(-5.1%)
Mar 1997
-
-$40.90M(-8.2%)
Dec 1996
-$37.80M(-25.6%)
-$37.80M(-5.9%)
Sep 1996
-
-$35.70M(-7.9%)
Jun 1996
-
-$33.10M(-3.4%)
Mar 1996
-
-$32.00M(-6.3%)
Dec 1995
-$30.10M(-40.0%)
-$30.10M(-7.9%)
Sep 1995
-
-$27.90M(-7.3%)
Jun 1995
-
-$26.00M(-6.6%)
Mar 1995
-
-$24.40M(-13.5%)
Dec 1994
-$21.50M
-$21.50M(-9.7%)
Sep 1994
-
-$19.60M(-8.9%)
Jun 1994
-
-$18.00M(-11.8%)
Mar 1994
-
-$16.10M

FAQ

  • What is BioCryst Pharmaceuticals, Inc. annual retained earnings?
  • What is the all-time high annual retained earnings for BioCryst Pharmaceuticals, Inc.?
  • What is BioCryst Pharmaceuticals, Inc. annual retained earnings year-on-year change?
  • What is BioCryst Pharmaceuticals, Inc. quarterly retained earnings?
  • What is the all-time high quarterly retained earnings for BioCryst Pharmaceuticals, Inc.?
  • What is BioCryst Pharmaceuticals, Inc. quarterly retained earnings year-on-year change?

What is BioCryst Pharmaceuticals, Inc. annual retained earnings?

The current annual retained earnings of BCRX is -$1.77B

What is the all-time high annual retained earnings for BioCryst Pharmaceuticals, Inc.?

BioCryst Pharmaceuticals, Inc. all-time high annual retained earnings is -$21.50M

What is BioCryst Pharmaceuticals, Inc. annual retained earnings year-on-year change?

Over the past year, BCRX annual retained earnings has changed by -$88.88M (-5.29%)

What is BioCryst Pharmaceuticals, Inc. quarterly retained earnings?

The current quarterly retained earnings of BCRX is -$1.76B

What is the all-time high quarterly retained earnings for BioCryst Pharmaceuticals, Inc.?

BioCryst Pharmaceuticals, Inc. all-time high quarterly retained earnings is -$16.10M

What is BioCryst Pharmaceuticals, Inc. quarterly retained earnings year-on-year change?

Over the past year, BCRX quarterly retained earnings has changed by -$35.71M (-2.07%)
On this page